✦ LIBER ✦

Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer

✍ Scribed by Aziz, Z. ;Zahid, M. ;Ahmed, Z. Vd Din ;Arshad, T.

Book ID: 108999913
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 673 KB
Volume: 28
Category: Article
ISSN: 0004-8291
DOI: 10.1111/j.1445-5994.1998.tb01975.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and ifosfamide in ovarian ca

Carboplatin and ifosfamide in ovarian cancer phase II and III trials

✍ E. Wiltshaw; T. J. Perren; I. D. Fryatt; P. R. Blake; P. Harper; M. Slevin 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 285 KB

Ifosfamide and vinorelbine in advanced p

Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II study

✍ Mario Nardi; Salvatore De Marco; Alessandra Fabi; Alessandra Aloe; Elena Magnani 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 60 KB

Phase II trial of didemnin-B in advanced

Phase II trial of didemnin-B in advanced epithelial ovarian cancer

✍ Joanna M. Cain; P. Y. Liu; David E. Alberts; Holly H. Gallion; Leslie Laufman; J 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 157 KB

Phase II trials of rhizoxin in advanced

Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer

✍ Kerr, DJ; Rustin, GJ; Kaye, SB; Selby, P; Bleehen, NM; Harper, P; Brampton, MH 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 396 KB

Phase II trial of intravenous hexamethyl

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer

✍ Mark D. Hauge; Harry J. Long; Lynn C. Hartmann; John H. Edmonson; Maurice J. Web 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 192 KB

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro